Search - tctmd.com

Displaying 461 - 480 of 556

Sort: Relevancy | Date

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Conference News ESC 2015

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Yael L. Maxwell

August 31, 2015

News Conference News ESC 2015

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Caitlin E. Cox

August 31, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Yael L. Maxwell

August 07, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

Advertisement

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content